Botulinum toxin type A for the treatment of the upper limb spasticity after stroke - A meta-analysis

被引：46

作者：

Cardoso, E ^{[1
]}

Rodrigues, B ^{[1
]}

Lucena, R ^{[1
]}

de Oliveira, IR ^{[1
]}

Pedreira, G ^{[1
]}

Melo, A ^{[1
]}

机构：

[1] Univ Fed Bahia, DINEP, Div Neurol, Salvador, BA, Brazil

来源：

ARQUIVOS DE NEURO-PSIQUIATRIA | 2005年 / 63卷 / 01期

关键词：

stroke; spasticity; botulinum toxin; rehabilitation;

D O I：

10.1590/S0004-282X2005000100006

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Muscle over-activity is one of the cardinal features of spasticity and it is a common disability of stroke patients. In this group, spasticity is responsible for several limitations that interfere in their daily activities and quality of life. To treat spasticity, neurologists usually prescribe drugs as baclofen, tizanidine or benzodiazepines or even use definitive treatment as phenol or surgery. Authors suggest the use of botulinum toxin type A (BTX-A) for spasticity in the upper limbs after stroke, but there are few papers with adequate methodology supporting this idea. In this article we summarize the data of previous double-blind, randomised clinical trials to asses, with a meta-analysis, if BTX-A is an adequate treatment for spasticity due to stroke. The results show a statistical superiority of BTX-A ov%r placebo on reducing muscle tone by the Modified Ashworth Scale (WMD = 0.95 [0.74 to 1.17]) in patients with post-stroke upper limb spasticity.

引用

页码：30 / 33

页数：4

共 14 条

[1] A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke [J].

Bakheit, AMO ;

Thilmann, AF ;

Ward, AB ;

Poewe, W ;

Wissel, J ;

Muller, J ;

Benecke, R ;

Collin, C ;

Muller, F ;

Ward, CD ;

Neumann, C .

STROKE, 2000, 31 (10) :2402-2406

[2] Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity [J].

Bakheit, AMO .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (05) :665-666

[3] A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke [J].

Bakheit, AMO ;

Pittock, S ;

Moore, AP ;

Wurker, M ;

Otto, S ;

Erbguth, F ;

Coxon, L .

EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) :559-565

[4]

Bhakca B, 2001, J NEUROL NEUROSUR PS, V70, P821

[5] BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].

BLASI, J ;

CHAPMAN, ER ;

LINK, E ;

BINZ, T ;

YAMASAKI, S ;

DECAMILLI, P ;

SUDHOF, TC ;

NIEMANN, H ;

JAHN, R .

NATURE, 1993, 365 (6442) :160-163

[6] INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY [J].

BOHANNON, RW ;

SMITH, MB .

PHYSICAL THERAPY, 1987, 67 (02) :206-207

[7] Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke [J].

Brashear, A ;

Gordon, MF ;

Elovic, E ;

Kassicieh, VD ;

Marciniak, C ;

Lee, CH ;

Jenkins, S ;

Turkel, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :395-400

[8] Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [J].

Jadad, AR ;

Moore, RA ;

Carroll, D ;

Jenkinson, C ;

Reynolds, DJM ;

Gavaghan, DJ ;

McQuay, HJ .

CONTROLLED CLINICAL TRIALS, 1996, 17 (01) :1-12

[9]

MIZRAHI EM, 1979, ANN NEUROL, V5, P494

[10] RECOVERY OF UPPER EXTREMITY FUNCTION IN STROKE PATIENTS - THE COPENHAGEN STROKE STUDY [J].

NAKAYAMA, H ;

JORGENSEN, HS ;

RAASCHOU, HO ;

OLSEN, TS .

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1994, 75 (04) :394-398

← 1 2 →